Evidence map›Paper›PMID 31575031›Full record

ArticleInternational journal of molecular sciences2019

iPSC-Derived Embryoid Bodies as Models of c-

Jin Wook Hwang, Christophe Desterke, Olivier Féraud, Stephane Richard, Sophie Ferlicot, Virginie Verkarre, Jean Jacques Patard, Julien Loisel-Duwattez, Adlen Foudi, Frank Griscelli and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Bioprinted research models of urological malignancy.Exploration (Beijing, China) · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. 3D Tumor Models in Urology.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jin Wook HwangINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. jinwook.hwang@inserm.fr.
Christophe DesterkeINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. christophe.desterke@inserm.fr.ORCID 0000-0001-7679-2524
Olivier FéraudINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. olivier.feraud@inserm.fr.
Stephane RichardRéseau National de Référence pour Cancers Rares de l'Adulte PREDIR, labellisé par l'INCa, et Service d'Urologie, AP-HP, Hôpital Bicêtre, 94270 Le Kremlin-Bicêtre, France; Génétique Oncologique EPHE, PSL Université, INSERM UMR 1186, Gustave Roussy, Faculté de Médecine et Université Paris-Sud, 94800 Villejuif, France. stephane.richard@u-psud.fr.ORCID 0000-0002-9859-9773
Sophie FerlicotINSERM, UMR 1186, Gustave Roussy, Paris-Sud University, Paris-Saclay University, 94800 Villejuif, France. sophie.ferlicot@aphp.fr.
Virginie VerkarreService d'Anatomie Pathologique, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France. virginie.verkarre@aphp.fr.
Jean Jacques PatardService d'Urologie, Centre Hospitalier de Mont de Marsan, 40024 Mont de Marsan, France. jean-jacques.patard@ch-mdm.fr.
Julien Loisel-DuwattezINSERM U1195, Université Paris Sud, Faculté de Médecine, APHP, Service de Neurologie, Hôpital Bicêtre, 94276 le Kremlin Bicêtre, France. julien.loisel-duwattez@inserm.fr.
Adlen FoudiINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. adlen.foudi@inserm.fr.ORCID 0000-0001-5002-5490
Frank GriscelliINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. frank.griscelli@gmail.com.
Annelise Bennaceur-GriscelliINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. abenna@hotmail.fr.ORCID 0000-0002-3557-4499
Ali G TurhanINSERM UMR-S 935 and ESTeam Paris Sud, Université Paris Sud, 94800 Villejuif, France. turviv33@gmail.com.ORCID 0000-0002-4861-0137
Université Paris-Sud · FRCentre Hospitalier Universitaire de Besançon · FRDélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary cancers with cancer-predisposing mutations represent unique models of human oncogenesis, as a driving oncogenic event is present in germline. Currently, there are no satisfactory models to study these malignancies. We report the generation of IPSC from the somatic cells of a patient with hereditary c-

Indexed as

MutationAllelesCarcinoma, PapillaryCarcinoma, Renal CellEmbryoid BodiesFluorescent Antibody TechniqueGene ExpressionGenotypeHumansImmunohistochemistryInduced Pluripotent Stem CellsMagnetic Resonance ImagingProto-Oncogene Proteins c-metReproducibility of ResultsMET protein, humanProto-Oncogene Proteins c-metc-Met mutationHereditary papillary renal cell carcinomainduced pluripotent stem cellkidney cancer organoids

Identifiers

PMID31575031
PMCPMC6801716
OpenAlexW2976601194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.